Lymphoproliferative Disorders: A Comprehensive Overview

 
LYMPHOPROLIFERATIVE
DISORDERS
BY:
 
DR. FATMA AL-QAHTANI
CONSULTANT HAEMATOLOGIST
HEAD OF HAEMATOLOGY DIVISION
DEPARTMENT OF PATHOLOGY
Lymphoproliferative disorders
S
everal clinical  conditions in which 
lymphocytes
 are produced in excessive
quantities ( Lymphocytosis)
Lymphoma
Malignant  lymphoid mass involving the lymphoid tissues (± other tissues e.g :
skin ,GIT ,CNS …)
Lymphoid leukemia
Malignant  proliferation of lymphoid cells in Bone marrow and peripheral blood (± other
tissues e.g : lymph nods ,spleen , skin ,GIT ,CNS …)
Definition
Lymphoproliferative disorders
Autoimmune
Infection
Malignant
 
 
Lymphocytosis
1- Viral infection :
Infectious mononucleosis 
,cytomegalovirus
,rubella, hepatitis, adenoviruses, varicella
….
 
2- Some bacterial infection:
 (Pertussis ,brucellosis …)
3-Immune : SLE , Allergic drug reactions
4- Other conditions:, splenectomy,
dermatitis ,hyperthyroidism  metastatic
carcinoma….)
5- Chronic lymphocytic leukemia (CLL)
6-Other lymphomas:
Mantle cell lymphoma ,Hodgkin lymphoma
An acute, infectious disease, caused by Epstein-Barr virus and
characterized by
 fever
swollen lymph nodes (painful)
Sore throat,
 atypical  lymphocyte
 Affect young people ( usually)
Infectious mononucleosis
Malignant Lymphoproliferative
Disorders
Lymphoid
progenitor
T-lymphocytes
Plasma
cells
B-lymphocytes
na
na
ï
ï
ve
ve
Malignant Lymphoproliferative disorders
Immature
ALL
Mature
Lymphoid leukemia
Lymphoma
CLL
Hairy cell leukemia
 T- prolymphocytic
leukemia
Leukemic phase of
lymphoma
Hodgkin lymphoma
 
Non Hodgkin lymphoma
T- cell neoplasm
Adult T leukemia lymphoma
Sezary syndrome
Large anaplastic T lymphoma
B- cell neoplasm
Burkitt lymphoma
Diffuse large B lymphoma
Follicular lymphoma
Multiple myeloma
90%
10%
 
stem
cell
 
lymphoid
progenitor
 
progenitor-B
 
pre-B
 
plasma cell
 
Mature naïve
 
B-cell
 
CD5,CD23
IgM or IgD
 
CD34 &TDT
CD 19
CD20
Surface immunoglobin
CD38 ,
CD138
IgG or IgA
 ,IgE
Germinal center
Mantle zone
 
GC blast
 
Centroblast
 
Centrocyte
 
CD 5
 
CD10
 
CD
5
 ,
CD23
 ,IgM or IgD
CD34 &TDT
CD 19
CD20
Surface immunoglobin
CD38 ,
CD138, CD56
IgG or IgA
 or IgE
ALL
CLL
t(11;14)
Cyklin D
Mantle lymphoma
CD 5
CD10
t(8;14)
C-myc
Burkitt lymphoma
t(3;14)
BCL-6
DLBCL
Follicular lymphoma
t(14;18)
BCL-2
Multiple myeloma
Chronic Lymphocytic Leukemia
Malignant neoplasim characterized by an increased number of
small, mature lymphocytes in the blood (>5,000 ) and bone
marrow (± spleen and lymph node)
 
The most common adult leukemia (~25% of adult leukemias)
 
The median age  is ~55 to 65 years. ( rare < 40 years).
 
1.5 to 2 times more common in men than women
.
Features of CLL
 40% of patients are asymptomatic at diagnosis.
Moderate lymphadenopathy and splenomegaly
Lymphocytosis (>5,000):
Small mature-appearing lymphocytes
• Condensed (“soccer ball”) nuclear chromatin
• Numerous “smudge cells”
Predisposition to infection
Autoimmune phenomena (autoimmune hemolytic anemia)
Transformation to large cell lymphoma (Richter’s syndrome)
CLL Staging
Rai Staging
Prognosis
Watch
&wait
± 
chemo
FCR
 High-grade non-Hodgkin's B-cell lymphoma which is rapidly growing
and highly aggressive with extremely short doubling time (24 hrs)
 
Types of Burkitt's lymphoma
 
1-Endemic
: associated with chronic malaria and EBV In equatorial
Africa . It particularly affects the jaw, other facial bone and breast.
 
Sporadic
: occurs throughout the world and affects GIT.
 
Immunodeficiency-associated
: associated with HIV infection or the
use of immunosuppressive drugs
Burkitt's lymphoma
Morphology
BMA
Biobsy
Homogenous  medium size cells with
round nuclei and deeply basophilic
and vacuolated cytoplasm
Diffuse infiltration with "starry sky”
(Macrophages engulfing the apoptotic
cells)
Highly associated with t(8;14):
Translocation of the c-MYC proto-oncogene at chromosome  8
to immunoglobulin gene at chromosome 14
The c-MYC  is nuclear transcription factor .
 Burkitt’s lymphoma is the 
fastest growing tumor 
in humans.
Genetics of BL
After 25 D
of intensive
chemotherapy
 Clinical Presentation
Cure rate:
90% at  early phase
70%  at advance disease
FL is malignant proliferation of germinal center B cells centrocyte which
has at least a partially follicular pattern.
 
Due to overexpression o f Bcl2 caused by t(14;18) .
Most common type of “indolent” lymphoma (25% ).
 
Presented as:
 Lymphadenopathy (100%)
splenomegaly (80%)
 BM involvement (60%)
  blood involvement (40%).
 
 Indolent but  incurable (some exceptions)
Follicular lymphoma
Immunophenotyping:
Positive for CD10,CD20 and Bcl2
Negative for CD5 ( in most cases)
CD10
BCL2
CD5
Diagnosis
Median survival is around 10 years.
Transformation to aggressive lymphoma (DLBCL) can occur.
Low grade FL
 FL in transformation
Aggressive
transformation (DLBCL)
Watch and weight
(most often)
Chemotherapy
 Aggressive
Chemotherapy(± SCT)
Management
Malignant  B  neoplasm characterized by a triad of abnormalities:
• Accumulation of plasma cells in the bone marrow
•Lytic  Bone lesions
• Production of a monoclonal immunoglobulin (Ig) or Ig fragments
Multiple Myeloma
For reading
Pathogenesis of MM
 
Hodgkin lymphoma
 
Thomas Hodgkin
(1798-1866)
Classical Hodgkin Lymphoma
Indolent malignant lymphoma  characterized by :
 
 1- presence of few large binucleated cells (Reed-Sternberg ) surrounded by
reactive cells (lymphocytes, plasma cells ,eosinophils)
 
2- Involving  cervical lymph nodes in young adults (most often )
 
germinal
centre
B cell
 
transforming
event(s)
 
loss of apoptosis
 
RS 
cell
 
inflammatory
response
 
E
B
V
?
cytokines
A possible model of pathogenesis
CD 30
CD 15
Diagnosis of Hodgkin Lymphoma
For reading
Slide Note
Embed
Share

Lymphoproliferative disorders encompass various clinical conditions involving the excessive production of lymphocytes, such as lymphoma and lymphoid leukemia. This article delves into the definitions, causes, and specific types of lymphoproliferative disorders, including infectious mononucleosis and malignant lymphoproliferative diseases. Detailed explanations of lymphocytosis and different lymphomas are also provided, shedding light on these conditions for a better understanding.

  • Lymphoproliferative Disorders
  • Lymphoma
  • Leukemia
  • Infectious Mononucleosis
  • Malignant Lymphoproliferative

Uploaded on Sep 14, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. LYMPHOPROLIFERATIVE DISORDERS BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST HEAD OF HAEMATOLOGY DIVISION DEPARTMENT OF PATHOLOGY

  2. Definition Lymphoproliferative disorders Several clinical conditions in which lymphocytes are produced in excessive quantities ( Lymphocytosis) Lymphoma Malignant lymphoid mass involving the lymphoid tissues ( other tissues e.g : skin ,GIT ,CNS ) Lymphoid leukemia Malignant proliferation of lymphoid cells in Bone marrow and peripheral blood ( other tissues e.g : lymph nods ,spleen , skin ,GIT ,CNS )

  3. Lymphoproliferative disorders Infection Autoimmune Malignant

  4. Lymphocytosis 1- Viral infection : Infectious mononucleosis ,cytomegalovirus ,rubella, hepatitis, adenoviruses, varicella . 2- Some bacterial infection: (Pertussis ,brucellosis ) 3-Immune : SLE , Allergic drug reactions 4- Other conditions:, splenectomy, dermatitis ,hyperthyroidism metastatic carcinoma .) 5- Chronic lymphocytic leukemia (CLL) 6-Other lymphomas: Mantle cell lymphoma ,Hodgkin lymphoma

  5. Infectious mononucleosis An acute, infectious disease, caused by Epstein-Barr virus and characterized by fever swollen lymph nodes (painful) Sore throat, atypical lymphocyte Affect young people ( usually) http://3.bp.blogspot.com/_jRgGstwXxTo/R-s0hEFd6EI/AAAAAAAAFEA/CCIHiBbJTYw/s400/HEME013.jpg http://bioweb.uwlax.edu/bio203/s2009/weisser_mich/tonsils.JPG http://upload.wikimedia.org/wikipedia/commons/c/cf/Lymphadanopathy.JPG

  6. Malignant Lymphoproliferative Disorders

  7. ALL CLL Lymphomas germinalcenter MM na ve B-lymphocytes Plasma cells Lymphoid progenitor T-lymphocytes AML Myeloproliferative disorders Hematopoietic stem cell Myeloid progenitor Neutrophils Eosinophils Basophils Monocytes Platelets Red cells

  8. Malignant Lymphoproliferative disorders Immature Mature ALL Lymphoid leukemia Lymphoma CLL Hairy cell leukemia T- prolymphocytic leukemia Leukemic phase of lymphoma Non Hodgkin lymphoma Hodgkin lymphoma B- cell neoplasm T- cell neoplasm 90% 10% Burkitt lymphoma Diffuse large B lymphoma Follicular lymphoma Multiple myeloma Adult T leukemia lymphoma Sezary syndrome Large anaplastic T lymphoma

  9. CD34 &TDT Surface immunoglobin CD 19 CD20 CD 5 CD10 Mantle zone stem cell Germinal center CD5,CD23 IgM or IgD lymphoid progenitor Mature na ve B-cell progenitor-B GC blast Centroblast pre-B Centrocyte plasma cell CD38 ,CD138 IgG or IgA ,IgE

  10. CD34 &TDT Surface immunoglobin CD 19 CD20 CD10 CD 5 Burkitt lymphoma DLBCL t(3;14) BCL-6 t(8;14) C-myc CD5 ,CD23 ,IgM or IgD CLL t(11;14) Cyklin D t(14;18) BCL-2 Mantle lymphoma Multiple myeloma Follicular lymphoma ALL CD38 ,CD138, CD56 IgG or IgA or IgE

  11. Chronic Lymphocytic Leukemia Malignant neoplasim characterized by an increased number of small, mature lymphocytes in the blood (>5,000 ) and bone marrow ( spleen and lymph node) The most common adult leukemia (~25% of adult leukemias) The median age is ~55 to 65 years. ( rare < 40 years). 1.5 to 2 times more common in men than women.

  12. Features of CLL 40% of patients are asymptomatic at diagnosis. Moderate lymphadenopathy and splenomegaly Lymphocytosis (>5,000): Small mature-appearing lymphocytes Condensed ( soccer ball ) nuclear chromatin Numerous smudge cells Predisposition to infection Autoimmune phenomena (autoimmune hemolytic anemia) Transformation to large cell lymphoma (Richter s syndrome) http://www.pathpedia.com/education/eatlas/histopathology/blood_cells/chronic_lymphocytic_leukemia_(cll)_b-cell/chronic-lymphocytic-leukemia-%5b3-bl021-3%5d.jpeg?Width=600Height=450Format=4

  13. CLL Staging Rai Staging Prognosis Watch &wait chemo FCR

  14. Burkitt's lymphoma High-grade non-Hodgkin's B-cell lymphoma which is rapidly growing and highly aggressive with extremely short doubling time (24 hrs) Types of Burkitt's lymphoma 1-Endemic: associated with chronic malaria and EBV In equatorial Africa . It particularly affects the jaw, other facial bone and breast. Sporadic: occurs throughout the world and affects GIT. Immunodeficiency-associated: associated with HIV infection or the use of immunosuppressive drugs

  15. Morphology BMA Biobsy Burkitt lymphoma, touch prep, Wright stain.jpg http://www.pathpedia.com/education/eatlas/histopathology/lymph_node/burkitt_lymphoma/burkitt-lymphoma-%5b1-ln071-1%5d.jpeg?Width=600Height=450Format=4 Homogenous medium size cells with round nuclei and deeply basophilic and vacuolated cytoplasm Diffuse infiltration with "starry sky (Macrophages engulfing the apoptotic cells)

  16. Genetics of BL Highly associated with t(8;14): Translocation of the c-MYC proto-oncogene at chromosome 8 to immunoglobulin gene at chromosome 14 The c-MYC is nuclear transcription factor . Burkitt s lymphoma is the fastest growing tumor in humans.

  17. Clinical Presentation After 25 D of intensive chemotherapy Cure rate: 90% at early phase 70% at advance disease

  18. Follicular lymphoma FL is malignant proliferation of germinal center B cells centrocyte which has at least a partially follicular pattern. Due to overexpression o f Bcl2 caused by t(14;18) . Most common type of indolent lymphoma (25% ). Presented as: Lymphadenopathy (100%) splenomegaly (80%) BM involvement (60%) blood involvement (40%). Indolent but incurable (some exceptions)

  19. Diagnosis CD10 http://www.pathpedia.com/education/eatlas/histopathology/lymph_node/follicular_lymphoma/image_name_%E2%80%93_follicular-lymphoma-%5b3-ln013-1%5d-3.jpeg?Width=600Height=450Format=4 BCL2 Immunophenotyping: Positive for CD10,CD20 and Bcl2 Negative for CD5 ( in most cases) CD5

  20. Management Median survival is around 10 years. Transformation to aggressive lymphoma (DLBCL) can occur. http://hematologyoutlines.com/images/Follicular-lymphoma-high-power.jpg http://www.pathpedia.com/education/eatlas/histopathology/lymph_node/follicular_lymphoma/image_name_%E2%80%93_follicular-lymphoma-%5b8-ln069.jpeg?Width=600Height=450Format=4 http://www.pathpedia.com/education/eatlas/histopathology/lymph_node/follicular_lymphoma/follicular-lymphoma-%5b9-ln060-1%5d-9.jpeg?Width=600Height=450Format=4 Aggressive Low grade FL FL in transformation transformation (DLBCL) Watch and weight (most often) Aggressive Chemotherapy Chemotherapy( SCT)

  21. Multiple Myeloma Malignant B neoplasm characterized by a triad of abnormalities: Accumulation of plasma cells in the bone marrow Lytic Bone lesions Production of a monoclonal immunoglobulin (Ig) or Ig fragments

  22. Pathogenesis of MM For reading For reading

  23. Hodgkin lymphoma Thomas Hodgkin (1798-1866)

  24. Classical Hodgkin Lymphoma Indolent malignant lymphoma characterized by : 1- presence of few large binucleated cells (Reed-Sternberg ) surrounded by reactive cells (lymphocytes, plasma cells ,eosinophils) 2- Involving cervical lymph nodes in young adults (most often ) http://www.jpgathology.com/slides-13/slides/LymphNode_HodgkinsLymphoma_NS_ReedSternberg2.jpg

  25. A possible model of pathogenesis loss of apoptosis transforming event(s) EBV? cytokines germinal centre B cell RS cell inflammatory response

  26. Diagnosis of Hodgkin Lymphoma CD 15 CD 30 https://static.fishersci.com/images/F110468~wl.jpg http://www.bloodjournal.org/content/bloodjournal/96/9/3133/F1.large.jpg

  27. For reading For reading

More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#